Rosiglitazone-induced protection against myelotoxicity produced by 5-fluorouracil

European Journal of Pharmacology

Volumn 477, Issue 2, 2003, Pages 179-182

  Benko, Ilona ^a   Djazayeri, Katayoun ^a   Ábrahám, Csongor ^b   Zsuga, Judit ^a   Szilvássy, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b N Gene Res Labs Incorporation   (Hungary)

Author keywords

Bone marrow toxicity; CFU GM; Insulin sensitizer; Thiazolidinedione

Indexed keywords

FLUOROURACIL; GLUCOSE; INSULIN; INSULIN SENSITIZING AGENT; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINEMIA; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; BONE MARROW CELLS; COLONY-FORMING UNITS ASSAY; FEMALE; FLUOROURACIL; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; INSULIN RESISTANCE; MACROPHAGES; MICE; NEUTROPENIA; PROTECTIVE AGENTS; THIAZOLIDINEDIONES;

EID: 1642267451     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.021     Document Type: Article

References (13)

1. Argiles J.M., Lopez-Soriano F.J. Insulin and cancer. Int. J. Oncol. 18:2001;683-687.
2. Benko I., Hernádi F., Megyeri A., Kiss A., Somogyi G., Tegyey Z., Kraicsovits F., Kovács P. Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro. J. Antimicrob. Chemother. 43:1999;675-681.
3. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:1979;E214-E223.
4. Demetri G.D., Fletcher C.D., Mueller E., Sarraf P., Naujoks R., Campbell N., Spiegelman B.M., Singer S. Induction of solid tumor differentiation by the PPAR-gamma ligand troglitazone in patients with liposarcoma. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3951-3956.
5. Echarti C., Maurer H.P. Defined, serum-free culture conditions for the GM-micro-clonogenic assay using agar-capillaries. Blut. 59:1989;171-176.
6. Fujimura S., Suzumiya J., Nakamura K., Ono J. Effects of troglitazone on the growth and differentiation of hemopoietic cell lines. Int. J. Oncol. 13:1998;1263-1267.
7. Gilmore G.L., DePasquale D.K., Fischer B.C., Shadduck R.K. Enhancement of monocytopoiesis by granulocyte colony-stimulating factor. Exp. Hematol. 23:1995;1319-1323.
8. Mobest D., Mertelsmann R., Henschler R. Serum-free ex vivo expansion of CD34+ hematopoietic progenitor cells. Biotechnol. Bioeng. 60:1998;341-347.
9. Mueller E., Smith M., Sarraf P., Kroll T., Aiyer A., Kauffman D.S., Oh W., Demetri G., Figg W.D., Zhou X.P., Eng C., Spiegelman B.M., Kantoff P.W. Effects of ligand activation of PPAR-gamma in human prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10990-10995.
10. Ratajczak J., Zhang Q., Pertusini E., Wojczyk B.S., Wasik M.A., Ratajczak M.Z. The role of insulin and insulin-like growth factor-I in regulating human erythropoiesis. Leukemia. 12:1998;371-381.
11. Stoll B.A. Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention. Eur. J. Cancer Prev. 11:2002;319-325.
12. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
13. Yoshikawa T., Noguchi Y., Doi C., Makino T., Nomura K. Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition. 17:2001;590-593.